PTEN and PI3K/AKT in non-small-cell lung cancer

C Pérez-Ramírez, M Cañadas-Garre… - …, 2015 - Future Medicine
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. In the
last years, the identification of activating EGFR mutations, conferring increased sensitivity …

[HTML][HTML] Liquid biopsy in early stage lung cancer

C Pérez-Ramírez, M Cañadas-Garre… - … lung cancer research, 2016 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer-associated deaths worldwide. Surgery is the
standard treatment for early-stage non-small cell lung cancer (NSCLC). However, 30% to …

Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer

C Perez-Ramirez, M Canadas-Garre, MÁ Molina… - … Research/Reviews in …, 2017 - Elsevier
Although platinum-based chemotherapy remains the standard treatment for advanced
NSCLC patients, clinical outcomes are poor and most patients develop high-grade toxicities …

Pharmacist-led medication reconciliation to reduce discrepancies in transitions of care in Spain

MÁ Allende Bandrés, M Arenere Mendoza… - International journal of …, 2013 - Springer
Background Medication errors are one of the main causes of morbidity amongst hospital
inpatients. More than half of medication errors occur at 'interfaces of care', when patients are …

A new pharmaceutical care concept: more capable, motivated, and timely

R Morillo-Verdugo, MÁ Calleja-Hernández… - Hospital …, 2019 - journals.sagepub.com
Taking another differential leap, it has been years since the clinical practice model of the
American Society of Health-System Pharmacists advocated the use of pharmacotherapeutic …

Impact of implementing smart infusion pumps in a pediatric intensive care unit

S Manrique-Rodríguez… - American journal of …, 2013 - academic.oup.com
Purpose The impact of smart infusion pumps on the interception of errors in the
programming of iv drug administrations on a pediatric intensive care unit (PICU) is …

[HTML][HTML] Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results

…, G Ramirez, MA Calleja-Hernández… - European journal of …, 2017 - journals.lww.com
Background Biological agents, such as infliximab, have transformed the outcomes of
patients with immune-mediated inflammatory diseases. The advent of biosimilar treatment …

Prescribing errors intercepted by clinical pharmacists in paediatrics and obstetrics in a tertiary hospital in Spain

CM Fernandez-Llamazares… - European journal of …, 2012 - Springer
Purpose To assess the main differences in clinical significance of the prescribing errors
intercepted by clinical pharmacists in paediatrics and obstetrics and the reasons for these …

[HTML][HTML] Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program

S Sadyrbaeva-Dolgova, P Aznarte-Padial… - Journal of Infection and …, 2020 - Elsevier
Background Carbapenem antibiotics are considered the treatment of choice for serious
extended-spectrum beta-lactamase-producing Gram-negative bacteria infections. Our …

[HTML][HTML] A new definition and refocus of pharmaceutical care: the Barbate Document

R Morillo-Verdugo, MÁ Calleja-Hernández… - Farmacia …, 2020 - Elsevier
Objective To propose an updated definition of Pharmaceutical Care based on the Capacity-
Motivation-Opportunity (CMO) model and on the key elements and optimal activities for its …